|
Real-time Estimate
Cboe BZX
12:00:54 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 14.98 USD | -3.88% |
|
-1.64% | +54.22% |
| 08:24pm | Trump picks White House adviser Heidi Overton to run FDA, source says | RE |
| 08-14 | Replimune Group, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- REPL Stock
- Consensus Replimune Group, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
